Stockwatch

Date	Sym	Type	Headline
2024-04-23 07:00	UU:IPSC	News Release200	Century Therapeutics to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
2024-04-11 07:00	UU:IPSC	News Release200	Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
2024-04-08 16:05	UU:IPSC	News Release200	Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
2024-03-25 07:00	UU:IPSC	News Release200	Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
2024-03-19 07:00	UU:IPSC	News Release200	Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
2024-03-14 07:30	UU:IPSC	News Release200	Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
2024-03-05 18:03	UU:IPSC	News Release200	Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
2024-02-01 07:00	UU:IPSC	News Release200	Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
2023-12-09 12:00	UU:IPSC	News Release200	Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion ¢ „ ¢ Edits
2023-12-06 07:30	UU:IPSC	News Release200	Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus
2023-12-06 07:30	UU:IPSC	News Release200	Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus
2023-11-21 07:00	UU:IPSC	News Release200	Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference
2023-11-09 07:01	UU:IPSC	News Release200	Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
2023-11-09 07:00	UU:IPSC	News Release200	Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in Autoimmune and Inflammatory Diseases
2023-11-09 07:00	UU:IPSC	News Release200	Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer
2023-11-02 09:00	UU:IPSC	News Release200	Century Therapeutics to Present Initial Clinical Data Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion ¢ „ ¢ Edits at the 65th ASH Annual Meeting and Exposition
2023-09-26 07:00	UU:IPSC	News Release200	Century Therapeutics to Present at the Chardan 7th Annual Genetic Medicines Conference
2023-08-09 07:30	UU:IPSC	News Release200	Century Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
2023-05-11 07:30	UU:IPSC	News Release200	Century Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates